Novo Holdings A/S’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-118,383
| Closed | -$32.6M | – | 35 |
|
|
2024
Q3 | $32.6M | Hold |
118,383
| – | – | 1.62% | 19 |
|
|
2024
Q2 | $28.8M | Hold |
118,383
| – | – | 1.55% | 21 |
|
|
2024
Q1 | $17.7M | Hold |
118,383
| – | – | 1.22% | 27 |
|
|
2023
Q4 | $22.7M | Hold |
118,383
| – | – | 1.4% | 25 |
|
|
2023
Q3 | $21M | Hold |
118,383
| – | – | 1.55% | 24 |
|
|
2023
Q2 | $22.5M | Hold |
118,383
| – | – | 1.74% | 19 |
|
|
2023
Q1 | $23.7M | Buy |
118,383
+6,383
| +6% | +$1.28M | 1.56% | 20 |
|
|
2022
Q4 | $26.6M | Buy |
112,000
+12,000
| +12% | +$2.85M | 1.66% | 21 |
|
|
2022
Q3 | $20M | Buy |
100,000
+15,200
| +18% | +$3.04M | 0.95% | 22 |
|
|
2022
Q2 | $12.4M | Buy |
84,800
+59,800
| +239% | +$8.72M | 0.61% | 29 |
|
|
2022
Q1 | $4.08M | Hold |
25,000
| – | – | 0.22% | 47 |
|
|
2021
Q4 | $4.24M | Hold |
25,000
| – | – | 0.2% | 46 |
|
|
2021
Q3 | $4.72M | Sell |
25,000
-9,679
| -28% | -$1.83M | 0.24% | 43 |
|
|
2021
Q2 | $5.88M | Buy |
+34,679
| New | +$5.88M | 0.26% | 47 |
|